Last Updated: July 28, 2026

MIDODRINE Drug Patent Profile

Name: MIDODRINE Drug Patent, Exclusivity, and Generic Launch Dataset
Creator: DrugPatentWatch
License: https://www.drugpatentwatch.com/terms.php

✉ Email this page to a colleague

« Back to Dashboard

When do Midodrine patents expire, and when can generic versions of Midodrine launch?

Midodrine is a drug marketed by Alembic, Apotex, Aurobindo Pharma Ltd, Chartwell Rx, Impax Pharms, Mankind Pharma, Mylan Pharms Inc, Novugen, Ph Health, Rubicon Research, Unique, Xiromed, and Zydus Lifesciences. and is included in thirteen NDAs.

The generic ingredient in MIDODRINE is midodrine hydrochloride. There are thirteen drug master file entries for this compound. Thirty-three suppliers are listed for this compound. Additional details are available on the midodrine hydrochloride profile page.

DrugPatentWatch^® Litigation and Generic Entry Outlook for Midodrine

A generic version of MIDODRINE was approved as midodrine hydrochloride by MYLAN PHARMS INC on September 10^th, 2003.

Start Trial

AI Deep Research

Questions you can ask:

What is the 5 year forecast for MIDODRINE?
What are the global sales for MIDODRINE?
What is Average Wholesale Price for MIDODRINE?

Summary for MIDODRINE

US Patents:	0
Applicants:	13
NDAs:	13
Drug Prices:	Drug price information for MIDODRINE
DailyMed Link:	MIDODRINE at DailyMed

Drug patent expirations by year for MIDODRINE

US Patents and Regulatory Information for MIDODRINE

+ Get email alerts for changes to this table

Glossary

Subscribe to access the full database, or Start Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Unique	MIDODRINE HYDROCHLORIDE	midodrine hydrochloride	TABLET;ORAL	207613-002	Nov 2, 2018	AB	RX	No	No	⤷ Start Trial	⤷ Start Trial				⤷ Start Trial
Rubicon Research	MIDODRINE HYDROCHLORIDE	midodrine hydrochloride	TABLET;ORAL	212543-001	Aug 19, 2019	AB	RX	No	No	⤷ Start Trial	⤷ Start Trial				⤷ Start Trial
Unique	MIDODRINE HYDROCHLORIDE	midodrine hydrochloride	TABLET;ORAL	207613-003	Nov 2, 2018	AB	RX	No	No	⤷ Start Trial	⤷ Start Trial				⤷ Start Trial
Rubicon Research	MIDODRINE HYDROCHLORIDE	midodrine hydrochloride	TABLET;ORAL	212543-002	Aug 19, 2019	AB	RX	No	No	⤷ Start Trial	⤷ Start Trial				⤷ Start Trial
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

DrugChatter Q&A for MIDODRINE

Side effects of midodrine?
Midodrine generic and trade name?
Midodrine hydrochloride brand name?
Midodrine 5 mg tablet price?
Midodrine 2 5 mg tablet price?

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.